Literature DB >> 1775194

Carrier-mediated outward transport of dopamine from adrenergic varicosities of the vas deferens of reserpine-pretreated rats.

A Langeloh1, T Halbrügge, U Trendelenburg.   

Abstract

In vasa deferentia of reserpine-pretreated rats a carrier-mediated (i.e., desipramine-sensitive) outward transport of endogenous dopamine was induced by either tyramine or ouabain. The dopamine taking part in the efflux induced by tyramine (and the concomitant efflux of DOPAC) was derived from ongoing synthesis of dopamine. Inhibition of MAO trebled the rate of spontaneous efflux of dopamine and reduced the spontaneous efflux of DOPAC by 90%. After inhibition of MAO, desipramine caused a further five-fold increase in the basal efflux of dopamine with no change in the basal efflux of DOPAC. Inhibition of COMT failed to affect the spontaneous efflux of dopamine but increased that of DOPAC. It is concluded that, after depletion of the noradrenaline stores by pretreatment with reserpine, an outward transport of axoplasmic dopamine is induced by the same mechanisms that (without any pretreatment with reserpine) are known to initiate an outward transport of noradrenaline.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1775194     DOI: 10.1007/bf00174744

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  12 in total

1.  Dissociation constants and lipophilicity of catecholamines and related compounds.

Authors:  F Mack; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

2.  Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum. I. Release in the absence of vesicular transmitter stores.

Authors:  E M Parker; L X Cubeddu
Journal:  J Pharmacol Exp Ther       Date:  1986-04       Impact factor: 4.030

3.  Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria.

Authors:  D M Paton
Journal:  Br J Pharmacol       Date:  1973-12       Impact factor: 8.739

4.  Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat.

Authors:  E Nissinen; I B Lindén; E Schultz; S Kaakkola; P T Männistö; P Pohto
Journal:  Eur J Pharmacol       Date:  1988-08-24       Impact factor: 4.432

5.  Simulation of outward transport of neuronal 3H-noradrenaline with the help of a two-compartment model.

Authors:  E Schömig; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

6.  The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: multifactorial induction of outward transport.

Authors:  A Langeloh; H Bönisch; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

7.  The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline.

Authors:  A Langeloh; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

8.  The outward transport of axoplasmic noradrenaline induced by a rise of the sodium concentration in the adrenergic nerve endings of the rat vas deferens.

Authors:  N Stute; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-09       Impact factor: 3.000

9.  Assay of catecholamines and dihydroxyphenylethyleneglycol in human plasma and its application in orthostasis and mental stress.

Authors:  T Halbrügge; T Gerhardt; J Ludwig; E Heidbreder; K H Graefe
Journal:  Life Sci       Date:  1988       Impact factor: 5.037

10.  The energy requirements for the basal efflux of 3H-noradrenaline from sympathetically innervated organs.

Authors:  H Russ; E Schömig; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

View more
  2 in total

1.  Evidence for uptake1-mediated efflux of catecholamines from pulmonary endothelial cells of perfused lungs of rats.

Authors:  N N Westwood; D L Scarcella; L J Bryan-Lluka
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

Review 2.  Therapy with central active catechol-O-methyltransferase (COMT)-inhibitors: is addition of monoamine oxidase (MAO)-inhibitors necessary to slow progress of neurodegenerative disorders?

Authors:  T Müller; W Kuhn; H Przuntek
Journal:  J Neural Transm Gen Sect       Date:  1993
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.